NF1: Clinical Trials

1 trial for NF1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1

Follow NF1: new trials by email Literature Review of NF1 trials Research Report on NF1

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas
Tasigna - Neurofibromatosis, NF1
Early Phase 1CompletedIndiana University62011-01-012017-04-12

Narrower conditions

Neurofibroma (1)  ·  Neurofibroma, Plexiform (1)  ·  Neurofibromatoses (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplastic Syndromes, Hereditary (1)  ·  Nerve Sheath Neoplasms (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Neurocutaneous Syndromes (1)  ·  Neurodegenerative Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Peripheral Nervous System Diseases (1)  ·  Peripheral Nervous System Neoplasms (1)

Interventions

nilotinib (1)

Sponsors

Indiana University (1)

Countries

United States (1)

Top investigators

Melissa Markel, MD (1)